STOPP/START criteria for potentially inappropriate medications/potential prescribing omissions in older people: uptake and clinical impact

S McGettigan, D Curtin, D O'Mahony - Expert Review of Clinical …, 2023 - Taylor & Francis
Introduction STOPP/START criteria for potentially inappropriate medications (PIMs, STOPP)
and potential prescribing omissions (PPOs, START) have gained considerable interest and …

Adverse clinical outcomes associated with drug-related hospitalizations in people with dementia

AS Zaidi, GM Peterson, CM Curtain… - Expert Review of …, 2024 - Taylor & Francis
Background This study aimed to determine the clinical impact associated with adverse drug
reactions (ADRs) in patients with dementia. Research design and methods This case …

[HTML][HTML] Appeal for Increasing the Impact of Pharmacovigilance

AC Kant - Drug Safety, 2023 - Springer
Pharmacovigilance (PV) is defined as the science and activities related to detecting,
assessing, understanding and preventing adverse effects and other medicine-related …

Atuação da farmacovigilância hospitalar no manejo da síndrome de Stevens-Johnson: um relato de caso

AM DE OLIVEIRA, FR VARALLO - Revista Brasileira de Farmácia …, 2024 - rbfhss.org.br
Stevens-Johnson syndrome is a condition that is considered rare but of severe intensity,
potentially induced by medications, with antimicrobials being highlighted as the main …

[PDF][PDF] Butlletí de prevenció d'errors de medicació de Catalunya-2022, Volum 20, Número 03, juliol-setembre

D de Salut - 2022 - scientiasalut.gencat.cat
Recordem de forma molt sintètica que la dosi d'un medicament es refereix a la quantitat
(massa) de fàrmac, principi actiu o substància activa que, juntament amb els excipients i …